Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of success from a randomized trial

BACKGROUND: Early pregnancy loss (EPL) is a common event in the first trimester, occurring in 15–20% of recognized pregnancies. A common evidence-based medical regimen for EPL management uses the prostaglandin E1 analogue misoprostol 800 mcg self-administered vaginally. The clinical utility of this...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am J Obstet Gynecol
Hlavní autoři: SONALKAR, Sarita, KOELPER, Nathanael, CREININ, Mitchell D., ATRIO, Jessica M., SAMMEL, Mary D., McALLISTER, Arden, SCHREIBER, Courtney A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7529708/
https://ncbi.nlm.nih.gov/pubmed/32305259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2020.04.006
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky